Df. Sahm et Fc. Tenover, SURVEILLANCE FOR THE EMERGENCE AND DISSEMINATION OF ANTIMICROBIAL RESISTANCE IN BACTERIA, Infectious disease clinics of North America, 11(4), 1997, pp. 767
Surveillance of antimicrobial resistance among clinically relevant bac
teria provides important data that can be used to modify recommendatio
ns regarding empiric therapy for many infectious diseases. In the labo
ratory, suweillance must involve careful review of the susceptibility
results generated not only to validate the data as required for optima
l patient care but to detect the presence of novel and emerging resist
ance patterns. The data from the laboratory must be accurate because i
t serves as the basis for surveillance of resistance at the local, sta
te, national, and international levels. There are a number of surveill
ance systems conducted by the Centers for Disease Control and Preventi
on, state health departments, academic centers, and the pharmaceutical
industry that gather data on resistant organisms in the United States
and around the world.